Aspen Pharmacare Holdings Limited
Financial ratios & Valuation

Forward Multiples (2026 – 2027)

20262027
Price/Earnings ratio
5.74N/A
Price/Sales ratio
N/AN/A
Earnings per Share (EPS)
$1.14N/A

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
34.15555.42348.84247.91317.59207.91259.29155.37277.4722.7317.65207.91
Price/Sales ratio
4.9167.0843.1839.0618.9330.0030.2726.1135.632.231.7330.00
Price/Book Value ratio
5.2056.9139.8132.3012.3216.1816.1315.2917.881.170.9116.18
Price/Cash Flow ratio
36.99746.34273.70213.28112.01122.28167.50187.58262.7916.0812.49122.28
Price/Free Cash Flow ratio
73.995.97K494.19375.00277.94181.33336.83376.57620.19145.0925.02181.33
Price/Earnings Growth ratio
8.92-5.8913.339.68-4.671.96-35.263.15-9.310.010.00-4.67
Dividend Yield
0.50%0.60%0.93%1.12%3.03%N/AN/A1.80%1.78%1.52%2.13%N/A
Profitability Indicator Ratios
Gross Profit Margin
47.92%48.31%48.30%49.84%50.78%48.36%44.87%45.40%44.58%43.51%43.43%48.36%
Operating Profit Margin
23.26%26.12%25.72%25.25%26.59%22.66%21.37%23.88%22.02%15.65%15.65%22.66%
Pretax Profit Margin
18.00%17.13%15.04%17.60%6.61%12.47%15.85%21.06%16.10%12.78%12.78%6.61%
Net Profit Margin
14.40%12.07%12.37%15.75%5.96%14.43%11.67%16.80%12.84%9.85%9.85%5.96%
Effective Tax Rate
20%29.50%17.74%16.63%28.54%19.48%19.88%20.23%20.24%22.92%22.92%22.92%
Return on Assets
5.88%4.17%4.23%4.86%1.72%4.04%3.72%6.26%4.13%3.16%3.16%1.72%
Return On Equity
15.24%10.24%11.41%13.03%3.88%7.78%6.22%9.84%6.44%5.18%5.16%3.88%
Return on Capital Employed
12.61%11.32%12.54%9.91%9.18%7.35%10.25%11.28%8.57%6.09%6.09%7.35%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.80N/A
Quick Ratio
1.001.080.700.871.071.120.520.801.071.061.061.12
Cash ratio
0.390.510.300.390.440.390.230.260.470.500.500.44
Days of Sales Outstanding
79.871.30K1.29K1.18K1.31K1.53K1.14K1.18K1.60K84.0884.081.53K
Days of Inventory outstanding
209.68282.01241.59266.75307.71310.83253.78253.62298.46260.20259.81310.83
Operating Cycle
289.551.58K1.53K1.44K1.61K1.84K1.40K1.43K1.90K344.29343.901.84K
Days of Payables Outstanding
66.011.00K1.20K1.09K1.16K1.10K890.99959.741.14K63.1963.091.10K
Cash Conversion Cycle
223.54582.70331.32352.44454.24740.16509.60480.12764.41281.09280.80740.16
Debt Ratios
Debt Ratio
0.430.410.416.015.535.443.183.221.240.250.255.44
Debt Equity Ratio
1.131.021.1016.0912.4710.485.325.051.940.420.4210.48
Long-term Debt to Capitalization
0.420.430.400.920.910.89N/A0.700.190.220.220.89
Total Debt to Capitalization
0.530.500.520.940.920.910.840.830.650.290.290.91
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A136.42N/A
Cash Flow to Debt Ratio
0.120.070.130.000.000.010.010.010.030.170.170.00
Company Equity Multiplier
2.592.452.692.672.251.921.671.561.551.631.631.92
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.130.080.150.180.160.240.180.130.130.130.130.24
Free Cash Flow / Operating Cash Flow Ratio
0.50.120.550.560.400.670.490.490.420.110.490.40
Cash Flow Coverage Ratio
0.120.070.130.000.000.010.010.010.030.170.170.00
Short Term Coverage Ratio
0.360.290.330.040.050.080.010.030.040.560.560.05
Dividend Payout Ratio
17.30%336.26%327.59%279.87%962.90%N/AN/A280.59%494.62%34.62%34.62%N/A